Raymond James & Associates’s Elanco Animal Health ELAN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$6.81M	Sell	463,504 -777,405	-63%	-$10.8M	﹤0.01%	1444
2024 Q2	$17.9M	Buy	1,240,909 +28,436	+2%	+$454K	0.01%	833
2024 Q1	$19.7M	Sell	1,212,473 -2,059	-0.2%	-$32.2K	0.01%	784
2023 Q4	$18.1M	Buy	1,214,532 +199,238	+20%	+$2.26M	0.01%	782
2023 Q3	$11.4M	Buy	1,015,294 +688,779	+211%	+$8M	0.01%	968
2023 Q2	$3.28M	Buy	326,515 +251,708	+336%	+$2.34M	﹤0.01%	1761
2023 Q1	$703K	Buy	74,807 +4,677	+7%	+$55.2K	﹤0.01%	2697
2022 Q4	$857K	Buy	70,130 +895	+1%	+$11.2K	﹤0.01%	2526
2022 Q3	$859K	Sell	69,235 -148,627	-68%	-$2.6M	﹤0.01%	2501
2022 Q2	$4.28M	Buy	217,862 +24,573	+13%	+$582K	﹤0.01%	1498
2022 Q1	$5.04M	Sell	193,289 -791,994	-80%	-$21.1M	﹤0.01%	1505
2021 Q4	$28M	Buy	985,283 +25,223	+3%	+$785K	0.02%	589
2021 Q3	$30.6M	Buy	960,060 +90,909	+10%	+$3.05M	0.03%	519
2021 Q2	$30.2M	Sell	869,151 -227,481	-21%	-$7.5M	0.03%	514
2021 Q1	$32.3M	Buy	1,096,632 +88,881	+9%	+$2.73M	0.03%	456
2020 Q4	$30.9M	Buy	1,007,751 +271,085	+37%	+$8.27M	0.03%	443
2020 Q3	$20.6M	Buy	736,666 +220,665	+43%	+$5.59M	0.03%	525
2020 Q2	$11.1M	Sell	516,001 -52,993	-9%	-$1.17M	0.01%	777
2020 Q1	$12.7M	Buy	568,994 +195,428	+52%	+$5.35M	0.02%	641
2019 Q4	$11M	Buy	373,566 +45,207	+14%	+$1.23M	0.01%	860
2019 Q3	$8.73M	Buy	328,359 +126,124	+62%	+$3.78M	0.01%	921
2019 Q2	$6.84M	Buy	202,235 +5,210	+3%	+$169K	0.01%	1064
2019 Q1	$6.32M	Buy	197,025 +129,229	+191%	+$3.98M	0.01%	1065
2018 Q4	$2.14M	Buy	67,796 +7,407	+12%	+$243K	﹤0.01%	1614
2018 Q3	$2.11M	Buy	+60,389	New	+$2.12M	﹤0.01%	1782